NuVasive Investor Relations

NuVasive is a world leader in minimally invasive, procedurally integrated spine solutions. From complex spinal deformity to degenerative spinal conditions, NuVasive is transforming spine surgery with innovative technologies designed to deliver reproducible and clinically proven surgical outcomes.

Press Release

The NuVasive Spine Foundation(TM) Expands Global Impact to Support Patients in Need

SAN DIEGO, CA -- (Marketwired) -- 09/06/13 -- NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is excited to announce that the NuVasive Spine Foundation (NSF), a non-profit organization developed and managed by NuVasive,® raised more than $230,000 during the 6th Annual NSF San Diego Golf Tournament.

The annual NSF golf tournament raises money to support mission trips, sponsor patients, and purchase essential medical equipment for hospitals and clinics in need.

"Demonstrating an 'Attitude of Gratitude' is a core tenet of our A-Player standards and we are exceptionally proud to give back by providing life-changing surgeries to patients in need around the world," said Alex Lukianov, Chairman and Chief Executive Officer of NuVasive. "Patients receiving treatment through the Foundation are people who do not have access to high quality medical procedures or cannot afford the cost of back surgery. Thanks to surgeon volunteers and generous product and cash donations, the patients are able to regain their quality of life and, very often, return to a life without pain."

The NSF is committed to changing lives by bringing world-class surgeons and innovative spine surgery to disadvantaged communities across the globe. Patients receive surgical care that ranges from discectomies to severe deformity corrections. To date, the Foundation has supported 40 surgical mission trips with more than $11 million in donations and $7.5 million in product donated by NuVasive. In addition to the surgeons that volunteer their time and expertise, NuVasive donates products and funds generated by Shareowner-driven charity events. The Foundation has expanded their global impact providing for patients in 18 countries including Ethiopia, Syria, Turkey, Romania, Belize, India, Zimbabwe, and Kenya. The number of yearly missions has more than doubled from 2011 and the Foundation intends to grow even more significantly in the coming years.

Click here to watch a short video about the NSF:

For more information about the NuVasive Spine Foundation please visit:

About The NuVasive Spine Foundation

The NuVasive Spine Foundation (NSF) is a non-profit organization developed and managed by NuVasive, Inc., an innovative medical device company focused on developing minimally disruptive surgical products and procedures for the spine. NSF is dedicated to providing life-changing spine surgery to individuals around the world with limited access to high quality medical treatment. The Foundation works with committed surgeons to develop sustainable spine treatment programs and advance the quality of spine care in disadvantaged communities.

About NuVasive

NuVasive is an innovative global medical device company that is changing spine surgery with minimally disruptive surgical products and procedurally-integrated solutions for the spine. The Company is the 4th largest player in the $8.2 billion global spine market.

NuVasive offers a comprehensive spine portfolio of more than 80 unique products developed to improve spine surgery and patient outcomes. The Company's principal procedural solution is its Maximum Access Surgery, or MAS®, platform for lateral spine fusion. MAS was designed to provide safe, reproducible, and clinically proven outcomes, and is a highly differentiated solution with fully integrated neuromonitoring, customizable exposure, and a broad offering of application-specific implants and fixation devices designed to address a variety of pathologies.

Having pioneered the lateral approach to spine fusion, NuVasive continues to be at the forefront of the spine industry's shift toward less invasive solutions. The Company places a large focus on clinical research and support of the Society of Lateral Access Surgery, or SOLAS®, to expand the body of clinical evidence in support of NuVasive's minimally disruptive solutions and to drive adoption of its techniques. The Company's dedication to innovation continues to spawn game-changing technology such as the PCM® motion preserving disc for the cervical spine, XLIF® Corpectomy for tumor and trauma, and Armada®, which treats adult degenerative scoliosis in a less invasive fashion. The Company has also developed procedural solutions that completely redefine and improve upon traditional procedures like TLIF, PLIF, Posterior Fixation, and ALIF. NuVasive's solutions are increasingly being adopted internationally, as the Company lays the groundwork to continue growing as a global business and to offer industry-leading, Absolutely Responsive customer service to surgeons worldwide. NuVasive is focused on becoming a $1 Billion Start-up™; taking market share by maintaining a commitment to Superior Clinical Outcomes, Speed of Innovation®, and Absolute Responsiveness®.

NuVasive cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties that could cause actual growth and results to differ materially include, but are not limited to those risks and uncertainties more fully described in NuVasive's press releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.

Investor Contact:
Tina Jacobsen
NuVasive, Inc.
Email Contact

Media Contact:
Nicole Collins
NuVasive, Inc.
Email Contact

Source: NuVasive, Inc.